Concord Drugs Ltd — Important, 14-10-2025: Company Update

Concord Drugs has confirmed its compliance regarding the processing of dematerialized shares for the quarter ending September 30, 2025. Their Registrar and Share Transfer Agent verified that physical share certificates submitted by investors for dematerialization were efficiently cancelled and the depository's name was updated as the registered owner in the company's records. This ensures proper handling of investor shares as they transition from physical to electronic form, maintaining accurate ownership records and facilitating smoother trading for all shareholders. This update highlights the company's adherence to investor services protocols.